Short-term blood pressure variability assessed by ambulatory blood pressure monitoring as a predictor of subclinical target organ damage - Report - MDSpire
Advertisement
Short-term blood pressure variability assessed by ambulatory blood pressure monitoring as a predictor of subclinical target organ damage
Clinical Report: Ambulatory Blood Pressure Monitoring-Derived Short-Term BP Variability
Overview
This study evaluates the predictive value of short-term blood pressure variability (BPV) from 24-hour ambulatory blood pressure monitoring (ABPM) for subclinical target organ damage (TOD) in patients with essential hypertension.
Background
Hypertension is a major risk factor for cardiovascular disease, leading to target organ damage (TOD) that can progress to severe health outcomes. Recent studies suggest that blood pressure variability (BPV) may provide additional prognostic information beyond traditional blood pressure measurements.
Data Highlights
Parameter
TOD Group (n=94)
Non-TOD Group (n=82)
24-h SBP SD
Higher
Lower
Daytime SBP SD
Higher
Lower
Nighttime SBP SD
Higher
Lower
Nighttime SBP ARV
Higher
Lower
Key Findings
Nighttime SBP SD, 24-h SBP ARV, and nighttime SBP ARV were identified as independent predictors of subclinical TOD.
The TOD group exhibited significantly higher BPV parameters across 24-h, daytime, and nighttime periods (all P < 0.001).
ROC analysis indicated nighttime SBP SD had an AUC of 0.837, with a sensitivity of 89.4% and specificity of 78.0%.
Subgroup analyses confirmed nighttime SBP SD's predictive value for cardiac, vascular, and renal TOD.
24-h SBP ARV was predictive of cardiac and vascular injury.
Clinical Implications
The findings suggest that monitoring nighttime blood pressure variability can enhance the assessment of subclinical target organ damage in hypertensive patients. Clinicians may consider incorporating ABPM-derived BPV metrics into routine evaluations to better identify patients at risk for organ damage.
Conclusion
Nighttime systolic blood pressure variability is a predictor of subclinical target organ damage in hypertension.